The PANCAID project is a multi-site, interdisciplinary research consortium that involves 16 partners + 1 associated partner from eight countries, bringing together expertise from various fields such as oncology, molecular biology, bioinformatics, and clinical research. PANCAID is committed to fostering gender balance in decision making, ensuring gender balance in research teams, and integrating the gender dimension in research and innovation. Browse through the PANCAID team members:
-
Universitaetsklinikum Hamburg-Eppendorf (UKE)Hamburg, Germany (Coordinator)
-
Karolinska Institutet (KI)Stockholm, Sweden (Co-coordinator)
-
Spanish National Cancer Research Center (CNIO)Madrid, Spain
-
Medical University of Graz (MUG)Graz, Austria
-
Umeå University (UMEA)Umeå, Sweden
-
Pancreatic Cancer Europe ASBL (PCE)Brussels, Belgium
-
concentris research management gmbh (concentris)Fürstenfeldbruck, Germany
-
Universitätsklinikum Schleswig-Holstein (UKSH)Kiel, Germany
-
Centre Hospitalier Universitaire Montpellier (CHUM)Montpellier, France
-
Universitatsklinikum Heidelberg (UKHD)Heidelberg, Germany
-
Uppsala Universitet (UU)Uppsala, Sweden
-
The Hebrew University of Jerusalem (HUJI)Jerusalem, Israel
-
Collective Minds Radiology AB (SME) (CMR)Taby, Sweden
-
Maccabi Health Care Services Foundation (MACCABI)Tel Aviv, Israel
-
Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal (FIBIRYCIS)Madrid, Spain
-
The Chancellor Masters and Scholars of the University of Cambridge (UCAM)Cambridge, United Kingdom
-
Region Stockholm (RS)Stockholm, Sweden
-
ZAVA Global GmbH (SME) (ZAVA GL)Hamburg, Germany
